Evidence map›Paper›PMID 37180427›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2023

Design of a Real-World Observational Study in Previously Untreated and Minimally Treated Hemophilia A Patients: Protect-NOW.

Johannes Oldenburg, Susan Halimeh, Georgina W Hall, Robert Klamroth, Pascual Marco Vera, Martina Jansen, Mary Mathias

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Simoctocog alfa (NuwiqTherapeutic advances in hematology · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Johannes OldenburgInstitute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Susan HalimehCoagulation Centre Rhein-Ruhr, Duisburg, Germany.
Georgina W HallOxford Haemophilia and Thrombosis Comprehensive Care Centre, Oxford University Hospital NHS Foundation Trust, Children's Hospital Oxford, Oxford, United Kingdom.
Robert KlamrothDepartment of Haemophilia and Haemostasis, Vivantes Hospital Friedrichshain, Berlin, Germany.
Pascual Marco VeraDepartment of Haematology, University General Hospital of Alicante, Alicante, Spain.
Martina JansenOctapharma Pharmazeutika Produktionsges m.b.H., Vienna, Austria.
Mary MathiasHaemophilia Comprehensive Care Centre, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.
Great Ormond Street Hospital for Children NHS Foundation Trust · GBHospital General Universitario de Alicante Doctor Balmis · ESKlinikum im Friedrichshain · DEOctapharma (Austria) · ATOxford Health NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

coagulation factor VIIIhemophilia Ainhibitorspreviously untreated patientsreal-world study

Identifiers

PMID37180427
PMCPMC10171993
OpenAlexW4376140207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.